Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    RedHill Biopharma Ltd.

    NASDAQ: RDHL · Real-Time Price · USD
    1.97
    0.04 (2.07%)
    At close: Jun 06, 2025, 3:56 PM
    1.93
    -1.78%
    After-hours: Jun 06, 2025, 07:34 PM EDT

    RedHill Biopharma Statistics

    Share Statistics

    RedHill Biopharma has 2.29M shares outstanding. The number of shares has increased by -23.1% in one year.

    Shares Outstanding

    n/a
    		 2.29M

    Shares Change (YoY)

    n/a
    		 -23.1%

    Shares Change (QoQ)

    n/a
    		 -0.03%

    Owned by Institutions (%)

    n/a
    		 0.01%

    Shares Floating

    n/a
    		 2.28M

    Failed to Deliver (FTD) Shares

    n/a
    		 130,464

    FTD / Avg. Volume

    n/a
    		 52.39%

    Short Selling Information

    The latest short interest is 118.33K, so 5.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 118.33K

    Short % of Shares Out

    n/a
    		 5.16%

    Short % of Float

    n/a
    		 5.81%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -9255.45 and the forward PE ratio is null. RedHill Biopharma's PEG ratio is 91.97.

    PE Ratio

    n/a
    		 -9255.45

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 9514.37

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -16340.83

    P/FCF Ratio

    n/a
    		 -8159.96

    PEG Ratio

    n/a
    		 91.97
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for RedHill Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.54, with a Debt / Equity ratio of -0.08.

    Current Ratio

    n/a
    		 0.54

    Quick Ratio

    n/a
    		 0.37

    Debt / Equity

    n/a
    		 -0.08

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 -265.69

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $229,800

    Profits Per Employee

    n/a
    		 $-236,228.57

    Employee Count

    n/a
    		 35

    Asset Turnover

    n/a
    		 0.45

    Inventory Turnover

    n/a
    		 0.87

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -81.76% in the last 52 weeks. The beta is 4.22, so RedHill Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 4.22

    52-Week Price Change

    n/a
    		 -81.76%

    50-Day Moving Average

    n/a
    		 2.12

    200-Day Moving Average

    n/a
    		 5.72

    Relative Strength Index (RSI)

    n/a
    		 51.02

    Average Volume (20 Days)

    n/a
    		 249,031

    Income Statement

    In the last 12 months, RedHill Biopharma had revenue of 8.04M and earned -8.27M in profits. Earnings per share was 0.

    Revenue

    n/a
    		 8.04M

    Gross Profit

    n/a
    		 4.85M

    Operating Income

    n/a
    		 -14.61M

    Net Income

    n/a
    		 -8.27M

    EBITDA

    n/a
    		 -7.59M

    EBIT

    n/a
    		 -8.21M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 4.62M in cash and 356K in debt, giving a net cash position of 4.26M.

    Cash & Cash Equivalents

    n/a
    		 4.62M

    Total Debt

    n/a
    		 356K

    Net Cash

    n/a
    		 4.26M

    Retained Earnings

    n/a
    		 -414.8M

    Total Assets

    n/a
    		 18.04M

    Working Capital

    n/a
    		 -10.31M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.37M and capital expenditures -9K, giving a free cash flow of -9.38M.

    Operating Cash Flow

    n/a
    		 -9.37M

    Capital Expenditures

    n/a
    		 -9K

    Free Cash Flow

    n/a
    		 -9.38M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 60.31%, with operating and profit margins of -181.69% and -102.8%.

    Gross Margin

    n/a
    		 60.31%

    Operating Margin

    n/a
    		 -181.69%

    Pretax Margin

    n/a
    		 -102.8%

    Profit Margin

    n/a
    		 -102.8%

    EBITDA Margin

    n/a
    		 -94.42%

    EBIT Margin

    n/a
    		 -181.69%

    FCF Margin

    n/a
    		 -116.6%

    Dividends & Yields

    RDHL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for RDHL.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 20, 2024. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Aug 20, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -22.25

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist